Company news

Cipla Ltd news in 2026

Cipla Ltd's news releases, calls and decks from 2026, newest first.

View company

Cipla Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Q2FY27 Financial Results".

October 27, 2026

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US

September 4, 2026

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US

September 3, 2026

Cipla Ltd Press Release Aug 31 2026

August 31, 2026

Cipla Ltd Press Release Jul 23 2026

July 23, 2026

Press Release May 13 2026

May 13, 2026

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA

April 24, 2026

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

April 23, 2026

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis

April 2, 2026

Cipla strengthens US portfolio with the launch of generic Saxenda(R) (Liraglutide Injection) for weight management therapy

March 2, 2026

Cipla strengthens US portfolio with the launch of generic Saxenda for weight management therapy

March 2, 2026

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

February 27, 2026

Press Release Jan 23 2026

January 23, 2026

Decks in 2026